Synthetic cannabinoid-induced psychosis: two adolescent cases.
Olumide O
OO
Oluwabusi
Liudmila
L
Lobach
Umair
U
Akhtar
Branden
B
Youngman
Paul J
PJ
Ambrosini
D000293:Adolescent; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000068180:Aripiprazole; D001569:Benzodiazepines / Q000627:therapeutic use; D002186:Cannabinoids / Q000009:adverse effects*; D003702:Delusions / Q000139:chemically induced / Q000523:psychology; D015198:Designer Drugs; D006801:Humans; D008297:Male; D002189:Marijuana Abuse / Q000523:psychology*; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000188:drug therapy / Q000523:psychology*; D015363:Quinolones / Q000627:therapeutic use
D014150:Antipsychotic Agents; D002186:Cannabinoids; D015198:Designer Drugs; D010879:Piperazines; D015363:Quinolones; D001569:Benzodiazepines; D000068180:Aripiprazole; D000077152:Olanzapine